简介:目的:探讨三联术(白内障超声乳化吸除、后房型人工晶状体植入联合小梁切除术)治疗青光眼合并白内障患者的临床疗效。方法:青光眼合并白内障患者72例72眼行小梁切除联合白内障超声乳化吸除联合后房型人工晶状体植入术,观察术后视力、眼压、滤过泡及并发症等情况。结果:术后72例72眼患者视力均有不同程度的提高;术后眼压控制良好,术后3,18mo平均眼压分别为15.30±2.64mmHg和16.72±2.30mmHg,术后均无严重并发症。结论:小梁切除联合白内障超声乳化吸除联合后房型人工晶状体植入术具有切口小,眼压控制良好,能获得较满意的视力。
简介:目的探讨在巩膜扣带术中运用间接眼底镜进一步查找视网膜裂孔的意义.方法我科于2006年6月至2006年12月收治孔源性视网膜脱离患者中采用巩膜扣带手术治疗的病例共86例87眼,在术前查找视网膜裂孔的基础上,手术中运用间接眼底镜进一步查找视网膜裂孔,术后随访6-12个月.结果术后第3天视网膜下液吸收,视网膜完全复位83眼(95.4%),术前84眼检出裂孔(96.6%),在手术中有18眼(20.7%)检查出新视网膜裂孔.术中检出视网膜裂孔100%.结论在充分的术前检查基础上,强调在巩膜扣带术中运用间接眼底镜进一步查找视网膜裂孔,对眼底进行全面细致的检查是必要的,可以提高视网膜裂孔检出率和巩膜扣带术视网膜复位率.
简介:1.以下哪种情况引起青光眼的发病机理和其它的不一样:A)Sturge-Weber综合征B)甲状腺相关眼病c)无虹膜D)颈动脉海绵窦瘘2.和眼内压水平有关的主要因素包括以下,除了:A)睫状后长动脉收缩压B)房水生成率C)房水流出阻力D)上巩膜静脉压3.预测氩激光小梁成形术成功的最主要因素是:A)诊断(即青光眼的类型)B)小梁网色素程度
简介:AIM:Toassesstheeffectivenessofimmunosuppressantsintheprophylaxisofcornealallograftrejectionafterhigh-riskkeratoplastyandnormal-riskkeratoplasty.METHODS:WesearchedtheCochraneCentralRegisterofControlledTrials(CENTRAL),MEDLINE,EMBASE,CNKI,VIPandreferencelistsofarticles.Dateofmostrecentsearch:18June,2011.Allrandomisedcontrolledtrials(RCTs)assessingtheuseofimmunosupressantsinthepreventionofgraftrejection,irrespectiveofpublicationlanguage.Twoauthorsassessedtrialqualityandextracteddataindependently.Onlydichotomousoutcomes(cleargraftsurvival,ratioofimmunereactionsandsideeffects)wereavailableandwereexpressedasrelativerisk(RR)and95%confidenceintervals(CI).RESULTS:Sevenstudieswereincludedinthisreview.Inthecomparingofmycophenolatemofetil(MMF)withplacebo,theresultsshowedMMFcouldsignificantlyreduceimmunereactionscomparedwithplacebo(RR1.0895%Cl0.95to1.21),butnoeffectoncleargraftsurvival(RR1.1195%Cl0.90to1.35).Incleargraftsurvivalandimmunereactions,MMFandcyclosporineA(CsA)showedsimilareffect(RR1.1195%Cl0.90to1.35,andRR1.48,95%Cl0.56to3.93,respectively).Tacrolimus(FK506)andsteroidshowedsimilareffectsoncleargraftsurvivalandimmunereactions(RR0.32,95%CI0.02to6.21,andRR1.00,95%CI0.88to1.14,respectively).Nodrugrelativesideeffecthasbeenfound.CONCLUSION:MMFmayreduceimmunereactionsinbothnormal-riskandhigh-riskrejectionofpenetratingkeratoplasty.CsAandFK506showedsimilareffectsasMMF.However,duetothelackoflargeclinicaltrials,theevidenceremainweak,thequalityofevidenceswereratedasverylowtomoderate.Large,properlyrandomised,placebo-controlled,doublemaskedtrialsareneededtoevaluatetheeffectofimmunosuppressants.
简介:目的:评价非穿透性小梁手术和小梁切除对降低开角型青光眼患者眼压的疗效。方法:计算机检索Cocharane图书馆、PubMed(1966~2013)、Embase(1980~2013)、中国生物医学文献数据库(1979~2013)中关于非穿透性小梁手术和小梁切除术对降低开角型青光眼患者眼压的疗效的随机对照试验、同时筛检纳入文献的参考文献。对文献质量进行评价,对符合质量标准的随机对照试验(RandomizedControlledTrial,RCT)用RevMan4.2软件进行Meta分析。结果:共纳入10个RCT,7篇研究均显示,非穿透性小梁切除术与小梁切除术比较,小梁切除术能提高患者术后眼压降低的水平和手术的成功率,但是8篇研究均显示非穿透性小梁切除术较传统小梁切除术能更有效的降低术后并发症发生率。结论:与非穿透性小梁切除术相比,传统小梁切除术能够提高眼压的降低水平和手术成功率;而非穿透性小梁切除术能较好降低术后并发症的发生率。
简介:目的比较急性中心性浆液性脉络膜视网膜病变(CSC)的患侧与对侧眼视网膜频域相干光断层扫描(OCT)的图像特征。方法应用频域OCT对30例(60眼)单眼发病急性CSC患者患侧和对侧眼的黄斑部视网膜显微结构进行检测,比较患侧组与对侧组黄斑中心凹外核层厚度、光感受器层(IS/OS层)、视网膜色素上皮(RPE)形态差异。结果所有30例患者患侧眼均有不同程度黄斑部视网膜浆液性脱离,对侧眼中有4眼(13.3%)存在轻度视网膜浆液性脱离;患侧组黄斑中心凹外核层厚度均值为(95.32±24.87)μm,对侧组为(98.80±14.36)μm,两组差异无统计学意义(t=1.627,P=0.110)。患侧组中IS/OS层厚度均匀一致者12眼(40.0%),对侧组20眼(66.7%);患侧组IS/OS层厚度均匀一致伴内外节缺损、不均、凸起增厚者共18眼(60.O%),对侧组共10眼(33.3%),差异有统计学意义(X2=4.28,P=0.038)。患侧组中出现RPE异常者有24眼(80.0%),对侧组中有8眼(26.7%),差异有统计学意义(x。=17.143,P=0.000)。结论频域OCT能清晰显示急性CSC患者的细微病理结构改变,单眼发病CSC患者中一部分对侧眼存在IS/OS层和RPE异常,但是其发生率较患侧眼低。(中国眼耳鼻喉科杂志,2013,13:165—167)
简介:目的:观察超声乳化白内障吸出术联合人工晶状体(IOL)植入治疗激光周边虹膜切除术后闭角型青光眼的治疗效果。方法:激光周边虹膜切除术后闭角型青光眼并白内障患者39例(39眼),被分为两组,Ⅰ组须用抗青光眼药控制眼压,Ⅱ组不须用抗青光眼药控制眼压,患者均行超声乳化白内障吸出和折叠式人工晶状体植入术,术后随访3mo。结果:两组术后最佳矫正视力均较术前显著提高(P〈0.05)。术后3moⅠ组眼压为15.72±3.02mmHg,1/组为16.30±3.81mmHg,两组眼压均比术前明显下降,有显著性差别(P〈0.05)。Ⅰ组中央前房深度由术前1.64±0.45mm加深至术后3mo的3.21±0.41mm,Ⅱ组中央前房深度由术前1.92±0.52mm加深至术后3mo的3.18±0.39mm.两组术后中央前房深度均比术前明显加深,有显著性差异(P〈0.05),前房角明显增宽。结论:超声乳化白内障吸出和人工晶状体(IOL)植入术不仅能提高激光周边虹膜切除术后青光眼视力,而且可彻底解除闭角型青光眼的瞳孔阻滞。
简介:·AIM:Toreportvariousocularinjuriescausedbydurianfruit.·METHODS:Threecasesofocularinjuriesweredescribedinyoungpatients,duetoaccidentalfallofdurianfruitontheforeheadandface,whiletheyweretakingrest/sleeping/playingundertheduriantree.·RESULTS:Theocularinjuriesobservedwerelaceratinginjuryofcorneawithirisincarceration,hyphema,superficialpenetratinginjuryofscleraandanglerecessionglaucomaintherighteyeoffirstpatient;laceratinginjuryofcorneawithirisprolapseinthelefteyeofsecondpatient;subconjunctivalhaemorrhage,traumaticmydriasisandsuperficialpenetratinginjuryofsclera,commotionretinopathyandmacularedemainthelefteyeofthirdpatient.Visionimprovedtonormalinalltheeyesfollowingsurgical/medical/opticaltreatment.·CONCLUSION:Evidenceofpenetratinginjury(becauseofthorns)andbluntinjury(becauseofweight)canbeseenintheeyeswhendurianfruitfallsontheface.Visioncanberecoveredfullywithimmediateandappropriatetreatmentinthesecases.Theocularinjuriescanbepreventedbyeducatingthepublictowearprotectivemetalframewidegogglesandnottosleep/takerestundertheduriantree.
简介:Oculardrugtransportbarriersposeachallengefordrugdeliverycomprisingtheocularsurfaceepithelium,thetearfilmandinternalbarriersoftheblood-aqueousandblood-retinabarriers.Oculardrugdeliveryefficiencydependsonthebarriersandtheclearancefromthechoroidal,conjunctivalvesselsandlymphatic.Traditionaldrugadministrationreducestheclinicalefficacyespeciallyforpoorwatersolublemoleculesandfortheposteriorsegmentoftheeye.Nanoparticles(NPs)havebeendesignedtoovercomethebarriers,increasethedrugpenetrationatthetargetsiteandprolongthedruglevelsbyfewinternalsofdrugadministrationsinlowerdoseswithoutanytoxicitycomparedtotheconventionaleyedrops.Withtheaidofhighspecificityandmultifunctionality,DNANPscanberesultedinhighertransfectionefficiencyforgenetherapy.NPscouldtargetatcornea,retinaandchoroidbysurficialapplicationsandintravitrealinjection.ThisreviewisconcernedwithrecentfindingsandapplicationsofNPsdrugdeliverysystemsforthetreatmentofdifferenteyediseases.
简介:AIM:Toreportthelong-termvision-threateningcomplicationsinpatientswhounderwentphakicintraocularlens(pIOLs)implantationforhighmyopia.METHODS:Thisstudywasdesignedfromaconsecutiveseriesofphakicintraocularlenscomplicationandcorrectivesurgeries.Sixteeneyesof13patientshadimplantationofphakicintraocularlensforcorrectionhighmyopiaanddevelopedseriouscomplicationshavebeenincludedinthisstudy.Themeanageofpatientswas38.6±6.35y(range32-50y)andthemeantimeofhistoryofpIOLimplantationforhighmyopiawas6±2y(range2-10y).Beforecorrectivesurgery,bestspectaclecorrectivevisualacuity(BSCVA)rangedfromperceptionto20/200intheeyesinwhichseverecomplicationsoccurred.RESULTS:Cornealdecompensationoccurredin12eyesof9highmyopicpatientsafteranteriorchamberpIOLimplantation.Rhegmatogenousretinaldetachment(RRD)occurredin4eyesof4highmyopicpatientsfollowinganteriorchamberandposteriorchamberpIOLimplantation.Patientswithcornealdecompensation,hadcombinedproceduresconsistingofpIOLremovalandpenetratingkeratoplasty(PKP).RemovalsofpIOL,phacoemulsificationandparsplanavitrectomy(PPV)withsiliconeoiltamponadewereperformedinpatientswithRRD.Aftercorrectivesurgeries,allpatientsbutone(P+,patient2,righteye)achievedmoderateBSCVArangedfrom20/200to20/50atthelastvisit.CONCLUSION:PhakicIOLsmaybeeffectiveforthecorrectionofhighmyopia.AlthoughtheseIOLsmayhaveseverecomplicationsanditaffectssafetyandefficacyofthissurgery.Asseenhere,cornealdecompensationandrhegmatogenousretinaldetachmentarepossiblepostoperativevision-threateningcomplicationsofphakicIOLs.Patientsmustbecarefullyexaminedbeforeandaftersurgeryforpossibleendothelialcelllossandvitreoretinalproblems.